Eisana Health Selected for National Investor Pitch Event Focused on Healthcare Innovation

Eisana Health Recognized Among Top Impact-Driven Startups Addressing Critical Healthcare Challenges

We are excited to announce that Eisana Health has been selected as one of only four companies nationwide to present at the upcoming Superpowers for Good Live Pitch event on June 3, 2026.

Chosen from a highly competitive pool of applicants, Eisana Health will join an elite group of healthcare and clean technology innovators presenting their companies and missions to investors, industry experts, and a national television audience.

Hosted by The Super Crowd and broadcast live on the e360tv Network, the event highlights purpose-driven companies working to solve some of society's most pressing challenges through innovation and entrepreneurship.

Addressing an Unmet Need in Cancer Care

At Eisana Health, our mission is simple: improve quality of life for people undergoing cancer treatment.

We are developing a medical cooling device designed to help prevent chemotherapy-induced peripheral neuropathy (CIPN), one of the most common and debilitating side effects of chemotherapy. CIPN can cause numbness, tingling, pain, and loss of function in the hands and feet, often affecting patients long after treatment ends.

Despite the significant impact CIPN has on cancer survivors, effective preventative solutions remain limited. Eisana Health is working to change that.

The funding raised through our Regulation Crowdfunding campaign will support critical next steps, including product engineering, manufacturing readiness, and clinical studies necessary to bring this innovation to patients.

Recognition from Industry Experts

The companies selected for the event underwent extensive review by a panel of experienced crowdfunding and investment professionals.

According to the judging panel, healthcare companies were evaluated not only on the strength of their innovation, but also on their ability to demonstrate a clear path toward regulatory approval, commercialization, and meaningful patient impact.

We are honored that Eisana Health's vision, technology, and commitment to improving cancer care were recognized through this rigorous selection process.

Join Us Live on June 3

Eisana Health CEO Carole Spangler Vaughn will present our vision during the live broadcast on June 3 at 8:00 PM Eastern.

Following the event, attendees will have an opportunity to join an exclusive virtual session where they can meet founders, ask questions, and learn more about each company's investment opportunity.

Whether you are an investor, healthcare professional, cancer advocate, patient, or supporter of medical innovation, we invite you to tune in and learn more about how Eisana Health is working to improve outcomes for cancer patients.

About Eisana Health

Eisana Health is developing innovative medical technology designed to prevent chemotherapy-induced peripheral neuropathy, helping cancer patients maintain comfort, mobility, and quality of life throughout treatment. By addressing a significant unmet need in oncology care, Eisana Health is working to bring meaningful innovation to patients, caregivers, and healthcare providers.

To learn more about Eisana Health and our mission, explore our website or connect with us to follow our progress.